1. Home
  2. Publications
  1. Home
  2. Publications

Filters

Research Groups

Core Facilities

Start date
End date

Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial.
Authors: AR Clamp, EC James, IA McNeish, A Dean, J-W Kim, DM O'Donnell, J Hook, C Co...
E-pub date: 7 Dec 2019
Journal name: Lancet

A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases.
Authors: NS Meagher, L Wang, PF Rambau, MP Intermaggio, DG Huntsman, LR Wilkens, MA ...
E-pub date: 1 Dec 2019
Journal name: Mod Pathol

Optoacoustic Imaging Detects Hormone-Related Physiological Changes of Breast Parenchyma.
Authors: O Abeyakoon, S Morscher, N Dalhaus, SJ Ford, IA Mendichovszky, R Manavaki, ...
E-pub date: 1 Dec 2019
Journal name: Ultraschall Med

Quantitative phase and polarization imaging through an optical fiber applied to detection of early esophageal tumorigenesis.
Authors: GSD Gordon, J Joseph, MP Alcolea, T Sawyer, C Williams, CRM Fitzpatrick, PH...
E-pub date: 1 Dec 2019
Journal name: J Biomed Opt

Development of a blood oxygenation phantom for photoacoustic tomography combined with online pO2 detection and flow spectrometry (Erratum).
Authors: M Gehrung, SE Bohndiek, J Brunker
E-pub date: 1 Dec 2019
Journal name: J Biomed Opt

Population based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high grade serous ovarian cancer
Authors: H Song, E Dicks, JP Tyrer, M Intermaggio, G Chenevix-Trench, DD Bowtell, N ...
E-pub date: 29 Nov 2019
Journal name:

Abstract GMM-048: CTDNA RESPONSE TO THE PARP INHIBITOR RUCAPARIB PREDICTS PROGRESSION-FREE SURVIVAL AND BEST OVERALL RESPONSE ON THE ARIEL2 TRIAL
Authors: A Piskorz, D Robertson, KK Lin, J Morris, E Mann, A Oza, RL Coleman, DM O'M...
E-pub date: 15 Nov 2019
Journal name: Clinical Cancer Research

MDC1 PST-repeat region promotes histone H2AX-independent chromatin association and DNA damage tolerance.
Authors: I Salguero, R Belotserkovskaya, J Coates, M Sczaniecka-Clift, M Demir, S Jh...
E-pub date: 15 Nov 2019
Journal name: Nat Commun